Peter C. Grayson
Impact in
- Rheumatology top 0.1%
- Otitis Media and Relapsing Polychondritis
- Systemic Lupus Erythematosus Research
- Pulmonary and Respiratory Medicine top 0.2%
- Vasculitis and related conditions
Papers in
- Rheumatology 65
- Otitis Media and Relapsing Polychondritis 48
- Systemic Lupus Erythematosus Research 11
- Eosinophilic Disorders and Syndromes 7
-
- Vasculitis and related conditions 88
- Co-authors
- Peter A. Merkel (50 shared papers)Michael P. LaValley (3 shared papers)Mariana J. Kaplan (9 shared papers)Hyon K. Choi (1 shared paper)Seoyoung C. Kim (1 shared paper)Mark A. Ahlman (22 shared papers)Gunnar Tómasson (4 shared papers)Ravi Suppiah (17 shared papers)
- Journals
- Arthritis & Rheumatology (27 papers)Annals of the Rheumatic Diseases (21 papers)Lara D. Veeken (19 papers)Arthritis Care & Research (15 papers)Blood (13 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Peter C. Grayson
175 papers receiving 10.6k citations
Peter C. Grayson's Hit Papers
Peers
Comparison fields: 5 of 134
- Rheumatology 4.2k
- Pulmonary and Respiratory Medicine 5.2k
- Genetics 1.7k
- Nephrology 1.1k
- Immunology 1.5k
Countries citing papers authored by Peter C. Grayson
This map shows the geographic impact of Peter C. Grayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Grayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Grayson more than expected).
Fields of papers citing papers by Peter C. Grayson
This network shows the impact of papers produced by Peter C. Grayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Grayson. The network helps show where Peter C. Grayson may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter C. Grayson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease Hit paper breakdown → | 2020 | 827 |
| 2 | Hyperuricemia and incident hypertension: A systematic review and meta‐analysis Hit paper breakdown → | 2010 | 609 |
| 3 | 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Hit paper breakdown → | 2021 | 438 |
| 4 | 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis Hit paper breakdown → | 2021 | 380 |
| 5 | 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis Hit paper breakdown → | 2022 | 331 |
| 6 | 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis Hit paper breakdown → | 2022 | 284 |
| 7 | 2017 | 282 | |
| 8 | 2011 | 278 | |
| 9 | 2001 | 234 | |
| 10 | 2001 | 230 | |
| 11 | 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis Hit paper breakdown → | 2022 | 227 |
| 12 | 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis Hit paper breakdown → | 2022 | 205 |
| 13 | 2012 | 200 | |
| 14 | 2015 | 195 | |
| 15 | Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1 Hit paper breakdown → | 2021 | 188 |
| 16 | Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS Hit paper breakdown → | 2021 | 170 |
| 17 | Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study Hit paper breakdown → | 2022 | 168 |
| 18 | Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population Hit paper breakdown → | 2023 | 159 |
| 19 | 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis Hit paper breakdown → | 2022 | 156 |
| 20 | 2018 | 155 |
About Peter C. Grayson
Peter C. Grayson is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Genetics, Immunology and Hematology, having authored 181 papers that have together received 10.9k indexed citations. Recurring topics across this work include Vasculitis and related conditions (88 papers), Otitis Media and Relapsing Polychondritis (48 papers), Vascular Anomalies and Treatments (12 papers), Systemic Lupus Erythematosus Research (11 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), Atherosclerosis and Cardiovascular Diseases (8 papers) and Eosinophilic Disorders and Syndromes (7 papers). The work is most often cited by research in Rheumatology (4.2k citations), Pulmonary and Respiratory Medicine (5.2k citations), Genetics (1.7k citations), Nephrology (1.1k citations) and Immunology (1.5k citations). Peter C. Grayson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Peter A. Merkel, Michael P. LaValley, Mariana J. Kaplan, Hyon K. Choi, Seoyoung C. Kim, Mark A. Ahlman, Gunnar Tómasson, Ravi Suppiah, Raashid Ahmed Luqmani and Joanna C Robson. Their work appears in journals such as Arthritis & Rheumatology, Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Care & Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.